NP
IART icon

NorthRock Partners’s Integra LifeSciences IART Stock Holding History

NorthRock Partners’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,461
Closed -$230K – 784
2025
Q1 		$230K Sell
10,461
-623
-6% -$14.6K 0.01% 533
2024
Q4 		$251K Buy
+11,084
New +$242K 0.01% 518

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NorthRock Partners's IART Position: Q2 2025 in Review

NorthRock Partners sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 10,461 shares — an estimated $230K sold.

NorthRock Partners first reported a position in IART in Q4 2024 and held it in 2 quarters. The position peaked at $251K in Q4 2024. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

  • NorthRock Partners reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
  • NorthRock Partners sold 10,461 Integra LifeSciences shares in Q2 2025, an estimated $230K.
  • NorthRock Partners first reported a position in Integra LifeSciences in Q4 2024 and held it in 2 quarters.
  • NorthRock Partners's Integra LifeSciences position peaked at $251K in Q4 2024.
  • 208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on NorthRock Partners's 13F filing for Q2 2025, filed 25 Jul 2025.